These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1038 related articles for article (PubMed ID: 15830287)

  • 21. [Comparison of prognosis of small hepatocellular carcinoma patients with hepatitis B virus infection versus hepatitis C virus infection].
    Li HK; Qin Y; Li XM; Li Q
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):426-8. PubMed ID: 19567020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic resection for combined hepatocellular and cholangiocarcinoma.
    Liu CL; Fan ST; Lo CM; Ng IO; Lam CM; Poon RT; Wong J
    Arch Surg; 2003 Jan; 138(1):86-90. PubMed ID: 12511158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience.
    Cescon M; Cucchetti A; Grazi GL; Ferrero A; Viganò L; Ercolani G; Ravaioli M; Zanello M; Andreone P; Capussotti L; Pinna AD
    Arch Surg; 2009 Oct; 144(10):906-13. PubMed ID: 19841357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
    Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD
    Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Favorable long-term surgical outcomes of hepatocellular carcinoma in patients with hepatitis B envelope antibody.
    Ariizumi S; Kotera Y; Katagiri S; Yamamoto M
    J Surg Oncol; 2010 May; 101(6):471-5. PubMed ID: 20401917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic resection for hepatocellular carcinoma in elderly patients.
    Yeh CN; Lee WC; Jeng LB; Chen MF
    Hepatogastroenterology; 2004; 51(55):219-23. PubMed ID: 15011868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
    Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
    ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study.
    Kawano Y; Sasaki A; Kai S; Endo Y; Iwaki K; Uchida H; Shibata K; Ohta M; Kitano S
    Eur J Surg Oncol; 2009 Feb; 35(2):174-9. PubMed ID: 18325724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Koide N; Adachi W; Amano J
    Am J Gastroenterol; 2001 Apr; 96(4):1243-50. PubMed ID: 11316177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is hepatic resection absolutely contraindicated for hepatocellular carcinoma in Child-Pugh class C cirrhotic patients?
    Wu CC; Ho WL; Lin MC; Tang JS; Yeh DC; Liu TJ; P'eng FK
    Hepatogastroenterology; 1999; 46(26):635-9. PubMed ID: 10370588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longterm favorable results of limited hepatic resections for patients with hepatocellular carcinoma: 20 years of experience.
    Yamashita Y; Taketomi A; Itoh S; Kitagawa D; Kayashima H; Harimoto N; Tsujita E; Kuroda Y; Maehara Y
    J Am Coll Surg; 2007 Jul; 205(1):19-26. PubMed ID: 17617328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical Outcomes of Hepatic Resection for Hepatitis B Virus Surface Antigen-Negative and Hepatitis C Virus Antibody-Negative Hepatocellular Carcinoma.
    Yamashita Y; Imai D; Bekki Y; Kimura K; Matsumoto Y; Nakagawara H; Ikegami T; Yoshizumi T; Shirabe K; Aishima S; Maehara Y
    Ann Surg Oncol; 2015 Jul; 22(7):2279-85. PubMed ID: 25472646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
    Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of major hepatectomy for large hepatocellular carcinoma.
    Miyoshi A; Takahashi T; Otsuka T; Kohya N; Miyazaki K
    Hepatogastroenterology; 2009; 56(91-92):768-72. PubMed ID: 19621699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver.
    Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK; Yoo BC
    J Surg Oncol; 2014 Dec; 110(8):976-81. PubMed ID: 25171344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of antiviral therapy after resection of hepatocellular carcinoma in the immune-active phase of hepatitis B virus infection.
    Li N; Lai EC; Shi J; Guo WX; Xue J; Huang B; Lau WY; Wu MC; Cheng SQ
    Ann Surg Oncol; 2010 Jan; 17(1):179-85. PubMed ID: 19727956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of repeat hepatic resection for recurrent hepatocellular carcinomas.
    Nagano Y; Shimada H; Ueda M; Matsuo K; Tanaka K; Endo I; Kunisaki C; Togo S
    ANZ J Surg; 2009 Oct; 79(10):729-33. PubMed ID: 19878169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Hepatic Steatosis on Disease-Free Survival in Patients with Non-B Non-C Hepatocellular Carcinoma Undergoing Hepatic Resection.
    Nishio T; Hatano E; Sakurai T; Taura K; Okuno M; Kasai Y; Seo S; Yasuchika K; Mori A; Kaido T; Uemoto S
    Ann Surg Oncol; 2015 Jul; 22(7):2226-34. PubMed ID: 25395147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of risk factors for metabolic syndrome and non-alcoholic fatty liver disease on the progression and prognosis of hepatocellular carcinoma.
    Takamatsu S; Noguchi N; Kudoh A; Nakamura N; Kawamura T; Teramoto K; Igari T; Arii S
    Hepatogastroenterology; 2008; 55(82-83):609-14. PubMed ID: 18613418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is resection for large hepatocellular carcinoma in cirrhotic patients beneficial? Study of 38 cases.
    Abdel-Wahab M; Sultan A; el-Ghawalby A; Fathy O; el-Ebidy G; Abo-Zeid M; Aboel-Enin A; Abdallah T; Fouad A; el-Fiky A; Gadel-Hak N; Ezzat F
    Hepatogastroenterology; 2001; 48(39):757-61. PubMed ID: 11462920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.